GlassScriptPhysician profile
John P Fitzsimons
NPI 1780613240
$127,176.49
in general payments reported to CMS, 2019-2025
11 companies · $24K in 2025
The $24K reported for 2025 was more than what 94% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $384 · 2021: $3,480 · 2022: $24K · 2023: $38K · 2024: $37K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $99K · Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $99,078.34 |
| Food and Beverage | $234.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $125,071.93 | 2020-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $750.76 | 2021-2022 | |
| Terumo Medical Corporation | $409.79 | 2021 | |
| Bard Peripheral Vascular, INC. | $258.23 | 2022 | |
| Philips North America LLC | $204.14 | 2020 | |
| Tactile Systems Technology INC | $139.47 | 2020-2022 | |
| Cardiva Medical, INC. | $139.08 | 2021-2022 | |
| Nevro Corp. | $68.02 | 2024 | Senza |
| Boston Scientific Corporation | $63.62 | 2020 | |
| Medtronic, INC. | $36.82 | 2021-2022 | |
| Kci USA, INC. | $34.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fitzsimons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.